Sangamo BioSciences | SGMO - 流动负债





流动负债 更改 日
Alaunos Therapeutics USD 864K 269K 2026-06
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Amgen USD 25.5B 547M 2026-06
Bayer EUR 32.27B 1.19B 2026-06
BioCryst Pharmaceuticals USD 208.85M 13.46M 2026-06
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Cipla INR 69.77B 366.6M 2026-09
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.63M 596K 2026-06
CSL USD 4.61B 207M 2025-12
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Grifols EUR 2.37B 156.97M 2025-12
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
J&J USD 55.46B 562M 2026-09
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Merck USD 27.73B 786M 2026-06
Novartis USD 32.52B 777M 2026-09
Omeros USD 85.5M 2.28M 2025-06
Pfizer USD 31.73B 920M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 29.77B 2.16B 2026-09
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Tectonic Therapeutic USD 10.37M 2.59M 2026-06
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
Vertex Pharmaceuticals USD 5B 1.06B 2026-09